Treatment of tinnitus with cyclobenzaprine: An open-label study

International Journal of Clinical Pharmacology and Therapeutics

Volumn 50, Issue 5, 2012, Pages 338-344

  Vanneste, Sven ^a,b   Figueiredo, Ricardo ^c   De Ridder, Dirk ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c OTOSUL   (Brazil)

Author keywords

Cyclobenzaprine; Norepinephrine; Open label; Serotonin; Subgroups; Tinnitus

Indexed keywords

CYCLOBENZAPRINE;

ACOUSTIC STRESS; ADULT; ARTICLE; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TINNITUS; TREATMENT DURATION;

ADULT; AGED; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; TINNITUS;

EID: 84860712358     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP201617     Document Type: Article

References (56)

1. Baguley DM. Mechanisms of tinnitus. Br Med Bull. 2002; 63: 195-212. doi:10.1093/bmb/63.1.195 PubMed (Pubitemid 35175761)
2. Eggermont JJ, Roberts LE. The neuroscience of tinnitus. Trends Neurosci. 2004; 27: 676-682. doi:10.1016/j.tins.2004.08.010 PubMed (Pubitemid 39335838)
3. Heller AJ. Classification and epidemiology of tinnitus. Otolaryngol Clin North Am. 2003; 36: 239-248. doi:10.1016/S0030-6665(02)00160-3 PubMed (Pubitemid 36529941)
4. Axelsson A, Ringdahl A. Tinnitus - a study of its prevalence and characteristics. Br J Audiol. 1989; 23: 53-62. doi:10.3109/03005368909077819 PubMed (Pubitemid 19087668)
5. Crönlein T, Langguth B, Geisler P, Hajak G. Tinnitus and insomnia. Prog Brain Res. 2007; 166: 227-233. doi:10.1016/S0079-6123(07)66021-X PubMed (Pubitemid 47588071)
6. Scott B, Lindberg P. Psychological profile and somatic complaints between help-seeking and nonhelp- seeking tinnitus subjects. Psychosomatics. 2000; 41: 347-352. doi:10.1176/appi.psy.41.4.347 PubMed (Pubitemid 30439813)
7. Erlandsson SI, Holgers KM. The impact of perceived tinnitus severity on health-related quality of life with aspects of gender. Noise Health. 2001; 3: 39-51. PubMed
8. Jastreboff PJ. Phantom auditory perception (tinnitus): mechanisms of generation and perception. Neurosci Res. 1990; 8: 221-254. doi:10.1016/ 0168-0102(90)90031-9 PubMed
9. De Ridder D, De Mulder G, Verstraeten E, Sunaert S, Moller A. Somatosensory cortex stimulation for deafferentation pain. Acta Neurochir Suppl (Wien). 2007; 97: 67-74. doi:10.1007/978-3-211-33081-4-8 PubMed
10. Møller AR. Tinnitus and pain. Prog Brain Res. 2007; 166: 47-53. doi:10.1016/S0079-6123(0 7)660 04-X PubMed
11. Mühlnickel W, Elbert T, Taub E, Flor H. Reorganization of auditory cortex in tinnitus. Proc Natl Acad Sci USA. 1998; 95: 10340-10343. doi:10.1073/pnas.95.17.10340 PubMed (Pubitemid 28415343)
12. Salvi RJ, Wang J, Ding D. Auditory plasticity and hyperactivity following cochlear damage. Hear Res. 2000; 147: 261-274. doi:10.1016/S0378-5955(00)00136- 2 PubMed (Pubitemid 30658071)
13. Kaltenbach JA, Godfrey DA. Dorsal cochlear nucleus hyperactivity and tinnitus: are they related? Am J Audiol. 2008; 17: S148-S161. doi:10.1 04 4/1059-0889(2008/08-0004) PubMed
14. Elgoyhen AB, Langguth B. Pharmacological approaches to the treatment of tinnitus. Drug Discov Today. 2010; 15: 300-305. doi:10.1016/j.dr udis.2009.11.003 PubMed
15. Darlington CL, Smith PF. Drug treatments for tinnitus. Prog Brain Res. 2007; 166: 249-262. doi:10.1 016/S0079-6123(07)66023-3 PubMed
16. Dobie RA. A review of randomized clinical trials in tinnitus. Laryngoscope. 1999; 109: 1202-1211. doi:10.1097/00005537-199908000-00004 PubMed (Pubitemid 29379426)
17. Patterson MB, Balough BJ. Review of pharmacological therapy for tinnitus. Int Tinnitus J. 2006; 12: 149-159. PubMed (Pubitemid 46032585)
18. Dobie RA, Sakai CS, Sullivan MD, Katon WJ, Russo J. Antidepressant treatment of tinnitus patients: report of a randomized clinical trial and clinical prediction of benefit. Am J Otol. 1993; 14: 18-23. PubMed (Pubitemid 23037487)
19. Sullivan M, Katon W, Russo J, Dobie R, Sakai C. A randomized trial of nortriptyline for severe chronic tinnitus. Effects on depression, disability, and tinnitus symptoms. Arch Intern Med. 1993; 153: 2251-2259. doi:10.1001/archinte.1993.004101 90091011 PubMed
20. Zöger S, Svedlund J, Holgers KM. The effects of sertraline on severe tinnitus suffering - a randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol. 2006; 26: 32-39. PubMed doi:10.1097/01.jcp.0000195111. 86650.19
21. Mardini MK. Ear-clicking "tinnitus" responding to carbamazepine. N Engl J Med. 1987; 317: 1542. doi:10.1056/NEJM198712103172418 PubMed
22. Bauer CA, Brozoski TJ. Effect of gabapentin on the sensation and impact of tinnitus. Laryngoscope. 2006; 116: 675-681. doi:10.1097/01. MLG.0000216812.65206.CD PubMed
23. Guitton MJ, Wang J, Puel JL. New pharmacological strategies to restore hearing and treat tinnitus. Acta Otolaryngol. 2004; 124: 411-415. doi:10.1080/00016480310000665 PubMed (Pubitemid 38797596)
24. Azevedo AA, Figueiredo RR. Treatment of tinnitus with acamprosate. Prog Brain Res. 2007; 166: 273-277. doi:10.1016/S0079-6123(07)66025-7 PubMed (Pubitemid 47595309)
25. Salembier L, De Ridder D, Van de Heyning PH. The use of flupirtine in treatment of tinnitus. Acta Otolaryngol Suppl. 2006; 126 (s556): 93-95. doi:10.1080/03655230600895242 PubMed
26. Johnson RM, Brummett R, Schleuning A. Use of alprazolam for relief of tinnitus. A double-blind study. Arch Otolaryngol Head Neck Surg. 1993; 119: 842-845. doi:10.1001/archotol.1993.01880200042006 PubMed (Pubitemid 23232291)
27. Kay NJ. Oral chemotherapy in tinnitus. Br J Audiol. 1981; 15: 123-124. doi:10.3109/03005368109081425 PubMed (Pubitemid 12161731)
28. Suckfüll M, Althaus M, Ellers-Lenz B, Gebauer A, Görtelmeyer R, Jastreboff PJ, Moebius HJ, Rosenberg T, Russ H, Wirth Y, Krueger H. A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus. BMC Ear Nose Throat Disord. 2011; 11: 1. doi:10.1186/1472-6815-11-1 PubMed
29. Zöger S, Svedlund J, Holgers KM. Relationship between tinnitus severity and psychiatric disorders. Psychosomatics. 2006; 47: 282-288. doi:10.1176/appi.psy.47.4.282 PubMed
30. Robinson SK, Viirre ES, Stein MB. Antidepressant therapy in tinnitus. Hear Res. 2007; 226: 221-231. doi:10.1016/j.heares.2006.08.004 PubMed (Pubitemid 46437287)
31. Robinson S. Antidepressants for treatment of tinnitus. Prog Brain Res. 2007; 166: 263-271. doi:10.1016/S0079-6123(07)66024-5 PubMed (Pubitemid 47593013)
32. Belli S, Belli H, Bahcebasi T, Ozcetin A, Alpay E, Ertem U. Assessment of psychopathological aspects and psychiatric comorbidities in patients affected by tinnitus. Eur Arch Otorhinolaryngol. 2008; 265: 279-285. doi:10.1007/s00405- 007-0440-8 PubMed
33. Langguth B et al. Tinnitus and depression. World J Biol Psychiatry, 2011.
34. Micó JA, Ardid D, Berrocoso E, Eschalier A. Antidepressants and pain. Trends Pharmacol Sci. 2006; 27: 348-354. doi:10.1016/j.tips.2006.05.004 PubMed (Pubitemid 43963184)
35. Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage. 2004; 28: 140-175. doi:10.1016/j.jpainsymman.2004.05. 002 PubMed
36. Tofferi JK, Jackson JL, O'Malley PG. Treatment of fibromyalgia with cyclobenzaprine: A metaanalysis. Arthritis Rheum. 2004; 51: 9-13. doi:10.1002/art.20076 PubMed
37. Dobie R. Clinical trials and drug therapy for tinnitus, in Snow JB (ed). Tinnitus: Theory and Management. BC Decker: Hamilton; 2004. p. 266-277.
38. Hiller W, Goebel G, Rief W. Reliability of selfrated tinnitus distress and association with psychological symptom patterns. Br J Clin Psychol. 1994; 33: 231-239. doi:10.1111/j.2044-8260.1994.tb01117.x PubMed (Pubitemid 24161919)
39. Vanneste S. et al. Different resting state brain activity and functional connectivity in patients who respond and not respond to bifrontal tDCS for tinnitus suppression. Exp Brain Res, 2011.
40. Vanneste S, Plazier M, Ost J, van der Loo E, Van de Heyning P, De Ridder D. Bilateral dorsolateral prefrontal cortex modulation for tinnitus by transcranial direct current stimulation: a preliminary clinical study. Exp Brain Res. 2010; 202: 779-785. doi:10.1007/s00221-010-2183-9 PubMed
41. Raiteri M, Del Carmine R, Cervoni AM, Levi G. Differential binding of antidepressants to noradrenaline and serotonin transport sites in central nerve endings. Eur J Pharmacol. 1979; 57: 407-416. doi:10.1016/0014-2999(79)90503-X PubMed (Pubitemid 9234338)
42. Reynolds WJ, Moldofsky H, Saskin P, Lue FA. The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia. J Rheumatol. 1991; 18: 452-454. PubMed
43. Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z, Woolsey J. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006; 34 (Database issue): D668-D672. doi:10.1093/nar/gkj067 PubMed
44. Gillman PK. Is there sufficient evidence to suggest cyclobenzaprine might be implicated in causing serotonin toxicity? Am J Emerg Med. 2009; 27: 509-510; author reply 510. doi:10.1016/j.ajem.2009.03.001 PubMed
45. Honda M, Nishida T, Ono H. Tricyclic analogs cyclobenzaprine, amitriptyline and cyproheptadine inhibit the spinal reflex transmission through 5-HT(2) receptors. Eur J Pharmacol. 2003; 458: 91-99. doi:10.1016/S0014-2999(02) 02735-8 PubMed (Pubitemid 36050705)
46. Shea JJ, Emmett JR, Orchik DJ, Mays K, Webb W. Medical treatment of tinnitus. Ann Otol Rhinol Laryngol. 1981; 90: 601-609. PubMed
47. Simpson JJ, Davies WE. A review of evidence in support of a role for 5-HT in the perception of tinnitus. Hear Res. 2000; 145: 1-7. doi:10.1016/S0378- 5955(00)00093-9 PubMed (Pubitemid 30365261)
48. Gallinat J, Senkowski D, Wernicke C, Juckel G, Becker I, Sander T, Smolka M, Hegerl U, Rommelspacher H, Winterer G, Herrmann WM. Allelic variants of the functional promoter polymorphism of the human serotonin transporter gene is associated with auditory cortical stimulus processing. Neuropsychopharmacology. 2003; 28: 530-532. doi:10.1038/sj.npp.1300042 PubMed
49. Levine RA. Somatic (craniocervical) tinnitus and the dorsal cochlear nucleus hypothesis. Am J Otolaryngol. 1999; 20: 351-362. doi:10.1016/S0196- 0709(99)90074-1 PubMed
50. Shore SE, Zhou J. Somatosensory influence on the cochlear nucleus and beyond. Hear Res. 2006; 216-217: 90-99. doi:10.1016/j.heares.2006.01.006 PubMed (Pubitemid 43867184)
51. Cacace AT, Lovely TJ, McFarland DJ, Parnes SM, Winter DF. Anomalous cross-modal plasticity following posterior fossa surgery: some speculations on gaze-evoked tinnitus. Hear Res. 1994; 81: 22-32. doi:10.1016/0378-5955(94)90149- X PubMed
52. Cacace AT, Cousins JP, Parnes SM, McFarland DJ, Semenoff D, Holmes T, Davenport C, Stegbauer K, Lovely TJ. Cutaneous-evoked tinnitus. II. Review of neuroanatomical, physiological and functional imaging studies. Audiol Neurootol. 1999; 4: 258-268. doi:10.1159/000013849 PubMed (Pubitemid 29366438)
53. Morgan DH. Tinnitus of TMJ origin: a preliminary report. Cranio. 1992; 10: 124-129. PubMed
54. Salvinelli F, Casale M, Paparo F, Persico AM, Zini C. Subjective tinnitus, temporomandibular joint dysfunction, and serotonin modulation of neural plasticity: causal or casual triad? Med Hypotheses. 2003; 61: 446-448. doi:10.1016/S0306-9877(03)00194-4 PubMed (Pubitemid 37494480)
55. Simmons R, Dambra C, Lobarinas E, Stocking C, Salvi R. Head, neck, and eye movements that modulate tinnitus. Semin Hear. 2008; 29: 361-370. doi:10.1055/s-0028-1095895 PubMed
56. Commissiong JW, Karoum F, Reiffenstein RJ, Neff NH. Cyclobenzaprine: a possible mechanism of action for its muscle relaxant effect. Can J Physiol Pharmacol. 1981; 59: 37-44. doi:10.1139/y81-007 PubMed (Pubitemid 11096018)